FIELD: ophthalmology. SUBSTANCE: method involves introducing 15-20 μg of supernatant of cultures of stimulated autologous mononuclear cells of peripheral blood in amounts of 0.1-0.15 ml into vitreous body so as to approximate a model to clinical run at amotio retinae. EFFECT: improved model.
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF PROPHYLAXIS OF PROLIFERATIVE TRANSFORMATIONS IN VITREOUS BODY IN EXPERIMENT | 1991 | 
 | RU2008861C1 | 
| METHOD OF PREVENTING COARSE CICATRIZATION OF CORNEA | 1991 | 
 | RU2012890C1 | 
| IMMUNOSTIMULATING AGENT | 1998 | 
 | RU2145500C1 | 
| METHOD OF ACUTE PNEUMONIA THERAPY | 1995 | 
 | RU2118159C1 | 
| METHOD FOR MODELING PROLIFERATIVE VITRORETINOPATHY | 1998 | 
 | RU2161335C2 | 
| METHOD OF THERAPY OF CHRONIC TONSILLITIS AND PHARYNGITIS | 1996 | 
 | RU2123362C1 | 
| METHOD FOR PERFORMING CHRONIC SINUSITIS THERAPY | 1998 | 
 | RU2164422C2 | 
| METHOD OF POLLINOSIS THERAPY | 1996 | 
 | RU2139742C1 | 
| METHOD FOR PROPHYLAXIS OF COMPLICATIONS AFTER EXTRACTING CATARACT | 1993 | 
 | RU2085158C1 | 
| METHOD OF PATIENT-SPECIFIC IMMUNOTHERAPY | 2009 | 
 | RU2414228C1 | 
Authors
Dates
1994-03-15—Published
1991-06-26—Filed